Efficacy and safety of IBI351 (GFH925) monotherapy in metastatic colorectal cancer harboring KRASG12C mutation: Preliminary results from a pooled analysis of two phase I studies.

被引：0
|
作者：
Yuan, Ying
Deng, Yanhong
Jin, Yongdong
Pan, Yueyin
Wang, Cunji
Wang, Zhiwu
Zhang, Zhiye
Meng, Xiangjiao
Hu, Yi
Zhao, Mingfang
Wang, Huijuan
Yang, Nong
Wu, Dongde
Dong, Xiaorong
Huang, Dingzhi
Sun, Meili
Liu, Lian
Hua, Dong
Guo, Zengqing
Ding, Ke-Feng
机构：
[1] Zhejiang Univ, Affiliated Hosp 2, Dept Med Oncol, Sch Med, Hangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou, Peoples R China
[3] Sichuan Canc Hosp, Dept Med Oncol, Chengdu, Peoples R China
[4] Anhui Prov Hosp, Dept Tumor Chemotherapy, Hefei, Peoples R China
[5] Hunan Tradit Chinese Med Co, Dept Oncol, Affiliated Hosp 1, Zhuzhou, Peoples R China
[6] Tangshan Peoples Hosp, Dept Radiochem 2, Tangshan, Peoples R China
[7] Henan Univ Sci & Technol, Dept Med Oncol, Affiliated Hosp 1, Luoyang, Peoples R China
[8] Shandong Prov Canc Hosp, Thorac Radiat Oncol Ward IV, Jinan, Peoples R China
[9] Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Med Ctr 1, Beijing, Peoples R China
[10] China Med Univ, Dept Med Oncol, Hosp 1, Shenyang, Peoples R China
[11] Henan Canc Hosp, Resp Dept, Zhengzhou, Peoples R China
[12] Hunan Canc Hosp, Lung & Gastrointestinal Oncol Dept, Changsha, Peoples R China
[13] Hubei Canc Hosp, Hepatopancreatobiliary Surg Dept, Wuhan, Peoples R China
[14] Huazhong Univ Sci & Technol, Dept Thorac Oncol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China
[15] Tianjin Med Univ Canc Inst & Hosp, Dept Pulm Oncol, Tianjin, Peoples R China
[16] Shandong First Med Univ, Dept Med Oncol, Cent Hosp, Jinan, Peoples R China
[17] Shandong Univ, Dept Med Oncol, Qilu Hosp, Jinan, Peoples R China
[18] Wuxi Peoples Hosp, Dept Oncol, Wuxi, Jiangsu, Peoples R China
[19] Fujian Canc Hosp, Fuzhou, Peoples R China
[20] Zhejiang Univ, Affiliated Hosp 2, Dept Colorectal Surg & Oncol, Key Lab Canc Prevent & Intervent,Minist Educ,Sch, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3586
引用
收藏
页数：1
相关论文
共 4 条
  • [1] Efficacy and safety of IBI351 (GFH925) monotherapy in metastatic colorectal cancer harboring KRASG12C mutation: Updated results from a pooled analysis of two phase I studies
    Yuan, Y.
    Deng, Y.
    Jin, Y.
    Pan, Y.
    Wang, C.
    Wang, Z.
    Zhang, Z.
    Meng, X.
    Hu, Y.
    Zhao, M.
    Wang, H.
    Yang, N.
    Wu, D.
    Dong, X.
    Huang, D.
    Sun, M.
    Liu, L.
    Hua, D.
    Guo, Z.
    Ding, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S1512 - S1512
  • [2] Efficacy and safety of IBI351 (GFH925), a selective KRASG12C inhibitor, monotherapy in patients (pts) with advanced nonsmall cell lung cancer (NSCLC): Initial results from a registrational phase II study
    Zhou, Q.
    Meng, X.
    Sun, L.
    Huang, D.
    Yang, N.
    Yu, Y.
    Zhao, M.
    Zhuang, W.
    Hu, Y.
    Pan, Y.
    Sun, M.
    Shan, J.
    Guo, R-H.
    Chu, Q.
    Xu, C.
    Lin, J.
    Huang, J.
    Huang, M.
    Shen, Y.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2023, 34 : S1662 - S1662
  • [3] Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study
    Zhou, Qing
    Meng, Xiangjiao
    Sun, Longhua
    Huang, Dingzhi
    Yang, Nong
    Yu, Yan
    Zhao, Mingfang
    Zhuang, Wu
    Guo, Renhua
    Hu, Yi
    Pan, Yueyin
    Shan, Jinlu
    Sun, Meili
    Yuan, Ying
    Fan, Yun
    Huang, Jianan
    Liu, Lian
    Chu, Qian
    Wang, Xiuwen
    Xu, Chongrui
    Lin, Jiaxin
    Huang, Jingjing
    Huang, Mengna
    Sun, Jiya
    Zhang, Sujie
    Zhou, Hui
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (12) : 1630 - 1639
  • [4] Phase I study of D-1553 to assess safety and efficacy in patients with non-small cell lung cancer (NSCLC) harboring KRASG12C mutation.
    Jian, Hong
    Song, Zhenbo
    Zhang, Yiping
    Li, Kunyan
    Yang, Nong
    Moore, Melissa
    Wang, Pingli
    Zhao, Yanqiu
    Gong, Yi
    Underhill, Craig
    Kim, Sang-We
    Yang, Cheng-Ta
    Xiang, Ziyong
    Shi, Zhe
    Zhang, Ling
    Wang, Yaolin
    Lu, Shun
    CANCER RESEARCH, 2022, 82 (12)
1